Breaking World News >>
  • Kuwait clinic offers new arthritis procedures

    The Hadi Clinic in Kuwait is introducing new and advanced surgery techniques for arthritis sufferers for the first time in the country...
    2008-11-01 07:22:21
  • Pakistani tribal militias walk tightrope in Taliban fight - International Herald Tribune

    Boston GlobePakistani tribal militias walk tightrope in Taliban fightInternational Herald Tribune&ampnbsp;- 1 hour agoBy Jane...
    2008-10-23 17:00:00
  • First gene behind clubfoot discovered

    Washington, Oct 24 ANI: Scientists at Washington University School of Medicine in St. Louis have discovered the first gene behind one of the most common birth defects in human - clubfoot. In a study on a multi-generation family with clubfoot, the researchers closed in on a gene called PITX1, which is critical for early development of lower limbs.The finding is the first step toward improved genetic counselling and the development of novel therapies, say the researchers. "To our knowledge this report is the first evidence for PITX1 mutation in human disease. Once we identified the mutation, we proved that all of the individuals in this family with lower extremity malformations also have the mutation. Having large families to work with is very helpful in genetic research," said Christina Gurnett, M.D., Ph.D., assistant professor of neurology, of pediatrics and of orthopedic surgery at the School of Medicine. During the study, the researchers examined the DNA of 35 extended family members of an infant male patient. The patients were the most severely affected in the family, had clubfoot in both feet, duplicated first toes and was missing the tibia in the right leg. The researchers visited the family members in their community to examine their lower limbs and to take DNA samples. They found that 13 family members were affected: Five additional family members had clubfoot, which was more severe in the right foot in three of them. Five others had lower limb abnormalities including flatfoot, an underdeveloped patella and hip dysplasia. And after conducting the genome-wide study, the researchers found a region on chromosome 5 that was common to all family members affected. Then they identified a mutation in a gene critical for early development of lower limbs called PITX1, which was found in all affected family members and in three carriers who showed no clinical symptoms. Dobbs, senior author of the study, said that the finding was an exciting step in developing a better understanding of the genetic basis of clubfoot, which affects about 1 in 1,000 new births. "Clubfoot is a complex disorder meaning that more than one gene as well as environmental factors will be discovered to play a role in its etiology. Identifying the genes for clubfoot will allow for improved genetic counseling and may potentially lead to new and improved treatment and preventive strategies for this disorder," said one of the senior authors of the study.Previous studies had shown a relation between PITX1 and the development of hindlimbs in other vertebrates. "It's our job to prove that this is going to be important for many kids with clubfoot. Until now, we didn't know whether clubfoot was a muscle, nerve, spinal cord or brain problem. Now, we have an idea that clubfoot may result from mutations of genes that are involved in early limb development," said Gurnett. The study appears in the forthcoming issue of the American Journal of Human Genetics. ANI
    2008-10-24 03:00:00
  • Hanger Orthopedic Group Inc. - On A Strong Footing

    Though not immune to market fluctuations, medical equipment companies like Hanger Orthopedic Group Inc. HGR make good stocks for a long-term hold. Since bottoming out in late April, Hanger Orthopedic stock has appreciated over 70% and currently trades around $17.
    2008-10-17 11:39:24
  • Waiting for word on Smith's shoulder

    Quarterback Alex Smith and the 49ers were still waiting Tuesday night for a determination from Dr. James Andrews on whether he will need more surgery on his injured right shoulder. Andrews, one of the top orthopedic surgeons in the country, performed Smith's...
    2008-09-12 16:32:13
  • Allergy tests useful before implanting devices

    NEW YORK Reuters Health - Patients with an allergy to metal, often first revealed when wearing certain jewelry, are also at risk for reactions to implanted medical devices made of metal, such as pacemakers and orthopedic prostheses.
    2008-09-10 17:18:15
  • Minimal stressing of knee may mean faster recovery

    New England Patriots quarterback Tom Brady will probably be out of action at least six to nine months after suffering a season-ending knee injury Sunday, according to orthopedic surgeons, but the good news is that quarterbacks typically return to pre-injury form more quickly than other athletes.
    2008-09-09 22:41:08
  • Injured Horsing Around With Stem Cells May Get You Back in the Saddle

    &ltp&gtDoctors might soon be able to regrow injured muscles, tendons and bones without invasive surgery, simply by injecting a person's own stem cells into the site of an injury. Veterinarians are already doing it with injured horses, and research into human applications is well under way.&ltp>The National Institutes for Health seem to think regenerating human muscle and bone using a person's own adult stem cells is nearly ready for prime time. Last week, the NIH announced to its staff that it's creating a bone marrow-stem cell transplant center within the NIH Clinical Research Center.&ltp>Researchers at the NIH labs in Bethesda, Maryland, are already growing human muscle, cartilage and spinal disks in vitro. The tissue isn't mechanically sound yet, says lead researcher Rocky Tuan, but that will come with further work.&ltp>"I have a piece of tissue that looks like a spinal disc, a sand bag, tough as nails on the outside and like sand on the inside," says Tuan, a Ph.D. and the senior investigator in the Cartilage and Orthopedics branch of the NIAMS. "The mechanical properties are lousy, but it's a beginning."&ltp>While the use of stem cells harvested from human embryos has been getting the most media attention, scientists and doctors have also been working with adult stem cells that also have the ability to become one with their environment and to replicate as cells of their adopted tissue. Using adult stem cells -- grown inside the body or in the lab -- has become accepted in the veterinary community, and horses have benefited greatly. Researchers are working to bring those same benefits to humans, but there are still hurdles left to clear.&ltp>The NIH project comes in part from what veterinarians have learned from injecting adult stem cells into valuable horses who've suffered injuries. In many cases, those horses' careers were saved when the stem cells regrew damaged tendons and ligaments.&ltp>Rodrigo Vazquez, a Southern California veterinarian, has been using adult stem cells to regrow damaged muscles in horses for several years. It's a fairly common procedure in the veterinary arena, and the results are impressive: One of Vazquez's patients is participating in this year's Olympics Dressage events; another is a prize-winning jumper. &ltp>The procedure is simple and straightforward. Inside a surgical suite at his equine hospital, Vazquez removes blood full of adult stem cells from the sternum of the anesthetized horse. &ltp>Then he rolls his stool to the other end of the horse, where ultrasound data has helped guide needles into the exact areas on the rear leg where the beautiful horse's ligaments are torn. He injects the stem cells into those spots. &ltp>"A few years ago, these injuries were career-ending," Vazquez says. Not any more. "In a month, the torn tissue will be completely regrown and healed." &ltp>Vazquez would like to put himself in his patients' place. He has had surgery several times for spinal injuries he incurred while lifting horses. Human medicine, unable to regrow or heal the injured spine, simply fuses the bone and tissue through a surgical procedure. At best, the surgery relieves some of the pain and restores some mobility. But it's not a true repair.&ltp>"I wish I could have had a procedure like this," Vazquez says of the treatment he gives horses. "This will lead to human treatments, but they can't move as fast as we can."&ltp>Tuan, who is using stem cells to cultivate experimental tendons and disks in his lab, thinks it's about time to look to treating humans.&ltp>An emerging body of scientific studies from all over the world -- including a cardiac study under way in Miami and a pediatric ACL anterior cruciate ligament study at the Harvard-affiliated Children's Hospital of Boston -- is showing that using a patient's own stem cells can prompt the growth of new muscle, from the knee to the heart. And the precursor step, using platelet-rich plasma for injuries, is on the verge of becoming mainstream.&ltp>Adult stem cells, particularly mesenchymal cells that come from muscle, bone and fat, are cells with a powerful ability to replicate and not a lot of personal identity. They easily take on the characteristics of surrounding cells and they tend to grow quickly once they get there. Ultrasounds of Vazquez's horses, for example, show regeneration of muscle in four to six weeks. &ltdiv id="embed_wide">&ltdiv id="pic">&lta href="#" onclick="launchWindow'/imageviewer/imagePath=/images/article/full/2008/08/cartilage_like_tissue_630px.jpg&ampimageCaption=Jon Snyder/Wired&ampimageCredit=','1092','827'" title="">&ltimgsrc="/images/article/full/2008/08/cartilage_like_tissue_630px.jpg" alt="">&ltdiv id="caption">The final product is this cartilage-like tissue grown around the scaffolding by NIH scientists. Tuan says the tissue resembles the human version, but may not be mechanically sound -- yet.&ltbr>&ltem&gtCourtesy NIAMS &ltp>Adult stem cells can be found all over the body, in bone and marrow. Tuan says they're also found in tonsils and in the placenta and umbilical cord, which suggest that the discarded body parts can be stored for later use. &ltp>Because researchers are using autologous cells -- from the patient's own body -- the research is not controversial. No one has challenged the ethics or funding of adult stem cell research the way embryonic stem cell studies have been challenged. And because adult stem cells are native to the patient's own body, the chances of a patient rejecting them are slim to none.&ltp>Tuan and his team have been able to coach adult stem cells to form muscle and disks using goo from the small intestine and a polymer scaffold to tell cells how to grow. But, he cautions, the primitive structures aren't ready to go into humans.&ltp>"After a few weeks of lab growth, it will turn into something that resembles a tendon, but it has to be the mechanical equivalent and we don't know that we're there," Tuan says. "Stem cells are very promising, but what they do for horses may not work so well for humans because humans are the hardest animal to rebuild."&ltp>Once they're perfected, Tuan sees a day when the tendons will change the dreaded surgery for torn anterior cruciate ligaments that sideline up to a quarter-million people in the United States and Canada every year.&ltp>"Often, that injury is a complete tear -- the ligament is snapped in two and the ends ball up and even if you untangle them and pull them together, they won't heal," he says. "So they take part of the patella tendon, which is short and tough, and stretch it and staple it to the bones. So not only is your ACL not working too well and you have to stretch it out, but your knee hurts like crazy."&ltp>"If we can learn to grow a tendon that works right, or figure out how to make the ACL heal back together, we can save a lot of people a lot of pain," he says.&ltp>In fact, doctors are already treating people with adult stem cells. Bone marrow transplants for cancer patients are basically stem cell therapy. But the marrow often comes from other people, and its primary purpose is to boost a weakened immune system, not to generate tissue.&ltp>And treating with platelet-rich plasma -- a blood product made by spinning a patient's blood in a centrifuge to concentrate the platelets -- is already in limited use and is becoming more widely accepted as a safe therapy. PRP is routinely used in cardiac surgery, where applying it to a cut sternum before closing has been shown to cut the infection rate in half. The plasma has growth factors that also promote healing.&ltp>"PRP helps recruit stem cells to the injury," says Dr. Allan Mishra, who has used PRP on its own and as part of surgery in sports injuries -- including treating tennis elbow and getting Stanford football player James McGillicuddy's patellar tendon to heal after his second surgery. "The body knows how to heal itself -- we're speeding up and concentrating the process."&ltp>Last year, Mishra wrapped up a study where he used platelet-rich plasma to treat the 20 worst tennis-elbow injuries he'd culled from more than 100 volunteers. "Ninety-three percent got better with a single injection and stayed better for two years," Mishra says. &ltp>The treatments are about one-tenth of the cost of surgery, or about $2,000 to $2,500, he says. The patient's blood is drawn, centrifuged by a specialist called a perfusionist, and injected, all in one visit. "I will guess that five years from now, insurance companies won't authorize surgery until the patient has tried and failed at PRP."&ltp>The obvious next step is to isolate the stem cells and send them to work, both inside and outside the body, researchers say. "PRP is reparative. Stem cells are regenerative," says Angela Nava, a perfusionist who processes both animal and human blood for PRP, stem cell and other procedures.&ltp>But getting from animals to humans is going to take a lot more research, according to Dr. Thomas Rando, an associate professor of neurology at Stanford University School of Medicine. Rando studies the body's signaling systems that tell stem cells what to do.&ltp>"We don't always know how stem cells, when injected into some tissues, work their magic," Rando said. "Veterinarians don't go back and study the horse's tendons to figure out what the stem cells did to promote healing."&ltp>"There are all kinds of ways stem cells could work. If we could understand how they are actually promoting better function of the tissue, we might be able to further improve their therapeutic effects," he adds.&ltp>Stem cell treatment is not without risks, researchers say. The worst-case scenario is that the stem cells could cause cancer -- or become cancerous themselves.&ltp>"You're putting in cells that want to grow. That has to be under control," Rando says. "Or we can end up with cancer."&ltp>Tuan also says that researchers don't entirely trust stem cells and their ability to adapt and grow.&ltp>"There's a nagging feeling that there's a cancer stem cell, that when it's agitated by exposure to carcinogens or radiation or something, it goes nuts, and that we can't identify it from the other stem cells," he says. "How do you find this bad boy and pull him out&ltp>"And there's a nagging worry it's the same cell. We only know these cells by what they've done, and by the time they've become cancer, it's too late."&ltbr style="clear: both;"/> &ltimg alt="" style="border: 0; height:1px; width:1px;" border="0" src="http://www.pheedo.com/img.phdoi=110d956a892b71e0185f81169e2f0b97" height="1" />&ltimg src="http://www.pheedo.com/feeds/tracker.phpi=110d956a892b71e0185f81169e2f0b97" style="display: none;" border="0" height="1" alt=""/>&ltdiv class="feedflare">&lta href="http://feeds.wired.com/~f/wired/medtecha=519dgK">&ltimg src="http://feeds.wired.com/~f/wired/medtechi=519dgK" border="0"> &lta href="http://feeds.wired.com/~f/wired/medtecha=YqA2sk">&ltimg src="http://feeds.wired.com/~f/wired/medtechi=YqA2sk" border="0"> &lta href="http://feeds.wired.com/~f/wired/medtecha=n4P9Ck">&ltimg src="http://feeds.wired.com/~f/wired/medtechi=n4P9Ck" border="0"> &lta href="http://feeds.wired.com/~f/wired/medtecha=MHIDSK">&ltimg src="http://feeds.wired.com/~f/wired/medtechi=MHIDSK" border="0">&ltimg src="http://feeds.wired.com/~r/wired/medtech/~4/367766936" height="1" />
    2008-08-21 16:17:17
  • Injured Horsing Around With Stem Cells May Get You Back in the Saddle

    &ltp&gtDoctors might soon be able to regrow injured muscles, tendons and bones without invasive surgery, simply by injecting a person's own stem cells into the site of an injury. Veterinarians are already doing it with injured horses, and research into human applications is well under way.&ltp>The National Institutes for Health seem to think regenerating human muscle and bone using a person's own adult stem cells is nearly ready for prime time. Last week, the NIH announced to its staff that it's creating a bone marrow-stem cell transplant center within the National Institute for Arthritis and Musculoskeletal and Skin Diseases.&ltp>Researchers at the NIH labs in Bethesda, Maryland, are already growing human muscle, cartilage and spinal disks in vitro. The tissue isn't mechanically sound yet, says lead researcher Rocky Tuan, but that will come with further work.&ltp>"I have a piece of tissue that looks like a spinal disc, a sand bag, tough as nails on the outside and like sand on the inside," says Tuan, a Ph.D. and the senior investigator in the Cartilage and Orthopedics branch of the NIAMS. "The mechanical properties are lousy, but it's a beginning."&ltp>While the use of stem cells harvested from human embryos has been getting the most media attention, scientists and doctors have also been working with adult stem cells that also have the ability to become one with their environment and to replicate as cells of their adopted tissue. Using adult stem cells -- grown inside the body or in the lab -- has become accepted in the veterinary community, and horses have benefited greatly. Researchers are working to bring those same benefits to humans, but there are still hurdles left to clear.&ltp>The NIH project comes in part from what veterinarians have learned from injecting adult stem cells into valuable horses who've suffered injuries. In many cases, those horses' careers were saved when the stem cells regrew damaged tendons and ligaments.&ltp>Rodrigo Vazquez, a Southern California veterinarian, has been using adult stem cells to regrow damaged muscles in horses for several years. It's a fairly common procedure in the veterinary arena, and the results are impressive: One of Vazquez's patients is participating in this year's Olympics Dressage events; another is a prize-winning jumper. &ltp>The procedure is simple and straightforward. Inside a surgical suite at his equine hospital, Vazquez removes blood full of adult stem cells from the sternum of the anesthetized horse. &ltp>Then he rolls his stool to the other end of the horse, where ultrasound data has helped guide needles into the exact areas on the rear leg where the beautiful horse's ligaments are torn. He injects the stem cells into those spots. &ltp>"A few years ago, these injuries were career-ending," Vazquez says. Not any more. "In a month, the torn tissue will be completely regrown and healed." &ltp>Vazquez would like to put himself in his patients' place. He has had surgery several times for spinal injuries he incurred while lifting horses. Human medicine, unable to regrow or heal the injured spine, simply fuses the bone and tissue through a surgical procedure. At best, the surgery relieves some of the pain and restores some mobility. But it's not a true repair.&ltp>"I wish I could have had a procedure like this," Vazquez says of the treatment he gives horses. "This will lead to human treatments, but they can't move as fast as we can."&ltp>Tuan, who is using stem cells to cultivate experimental tendons and disks in his lab, thinks it's about time to look to treating humans.&ltp>An emerging body of scientific studies from all over the world -- including a cardiac study under way in Miami and a pediatric ACL anterior cruciate ligament study at the Harvard-affiliated Children's Hospital of Boston -- is showing that using a patient's own stem cells can prompt the growth of new muscle, from the knee to the heart. And the precursor step, using platelet-rich plasma for injuries, is on the verge of becoming mainstream.&ltp>Adult stem cells, particularly mesenchymal cells that come from muscle, bone and fat, are cells with a powerful ability to replicate and not a lot of personal identity. They easily take on the characteristics of surrounding cells and they tend to grow quickly once they get there. Ultrasounds of Vazquez's horses, for example, show regeneration of muscle in four to six weeks. &ltdiv id="embed_wide">&ltdiv id="pic">&lta href="#" onclick="launchWindow'/imageviewer/imagePath=/images/article/full/2008/08/cartilage_like_tissue_630px.jpg&ampimageCaption=Jon Snyder/Wired&ampimageCredit=','1092','827'" title="">&ltimgsrc="/images/article/full/2008/08/cartilage_like_tissue_630px.jpg" alt="">&ltdiv id="caption">The final product is this cartilage-like tissue grown around the scaffolding by NIH scientists. Tuan says the tissue resembles the human version, but may not be mechanically sound -- yet.&ltbr>&ltem&gtCourtesy NIAMS &ltp>Adult stem cells can be found all over the body, in bone and marrow. Tuan says they're also found in tonsils and in the placenta and umbilical cord, which suggest that the discarded body parts can be stored for later use. &ltp>Because researchers are using autologous cells -- from the patient's own body -- the research is not controversial. No one has challenged the ethics or funding of adult stem cell research the way embryonic stem cell studies have been challenged. And because adult stem cells are native to the patient's own body, the chances of a patient rejecting them are slim to none.&ltp>Tuan and his team have been able to coach adult stem cells to form muscle and disks using goo from the small intestine and a polymer scaffold to tell cells how to grow. But, he cautions, the primitive structures aren't ready to go into humans.&ltp>"After a few weeks of lab growth, it will turn into something that resembles a tendon, but it has to be the mechanical equivalent and we don't know that we're there," Tuan says. "Stem cells are very promising, but what they do for horses may not work so well for humans because humans are the hardest animal to rebuild."&ltp>Once they're perfected, Tuan sees a day when the tendons will change the dreaded surgery for torn anterior cruciate ligaments that sideline up to a quarter-million people in the United States and Canada every year.&ltp>"Often, that injury is a complete tear -- the ligament is snapped in two and the ends ball up and even if you untangle them and pull them together, they won't heal," he says. "So they take part of the patella tendon, which is short and tough, and stretch it and staple it to the bones. So not only is your ACL not working too well and you have to stretch it out, but your knee hurts like crazy."&ltp>"If we can learn to grow a tendon that works right, or figure out how to make the ACL heal back together, we can save a lot of people a lot of pain," he says.&ltp>In fact, doctors are already treating people with adult stem cells. Bone marrow transplants for cancer patients are basically stem cell therapy. But the marrow often comes from other people, and its primary purpose is to boost a weakened immune system, not to generate tissue.&ltp>And treating with platelet-rich plasma -- a blood product made by spinning a patient's blood in a centrifuge to concentrate the platelets -- is already in limited use and is becoming more widely accepted as a safe therapy. PRP is routinely used in cardiac surgery, where applying it to a cut sternum before closing has been shown to cut the infection rate in half. The plasma has growth factors that also promote healing.&ltp>"PRP helps recruit stem cells to the injury," says Dr. Allan Mishra, who has used PRP on its own and as part of surgery in sports injuries -- including treating tennis elbow and getting Stanford football player James McGillicuddy's patellar tendon to heal after his second surgery. "The body knows how to heal itself -- we're speeding up and concentrating the process."&ltp>Last year, Mishra wrapped up a study where he used platelet-rich plasma to treat the 20 worst tennis-elbow injuries he'd culled from more than 100 volunteers. "Ninety-three percent got better with a single injection and stayed better for two years," Mishra says. &ltp>The treatments are about one-tenth of the cost of surgery, or about $2,000 to $2,500, he says. The patient's blood is drawn, centrifuged by a specialist called a perfusionist, and injected, all in one visit. "I will guess that five years from now, insurance companies won't authorize surgery until the patient has tried and failed at PRP."&ltp>The obvious next step is to isolate the stem cells and send them to work, both inside and outside the body, researchers say. "PRP is reparative. Stem cells are regenerative," says Angela Nava, a perfusionist who processes both animal and human blood for PRP, stem cell and other procedures.&ltp>But getting from animals to humans is going to take a lot more research, according to Dr. Thomas Rando, an associate professor of neurology at Stanford University School of Medicine. Rando studies the body's signaling systems that tell stem cells what to do.&ltp>"We don't always know how stem cells, when injected into some tissues, work their magic," Rando said. "Veterinarians don't go back and study the horse's tendons to figure out what the stem cells did to promote healing."&ltp>"There are all kinds of ways stem cells could work. If we could understand how they are actually promoting better function of the tissue, we might be able to further improve their therapeutic effects," he adds.&ltp>Stem cell treatment is not without risks, researchers say. The worst-case scenario is that the stem cells could cause cancer -- or become cancerous themselves.&ltp>"You're putting in cells that want to grow. That has to be under control," Rando says. "Or we can end up with cancer."&ltp>Tuan also says that researchers don't entirely trust stem cells and their ability to adapt and grow.&ltp>"There's a nagging feeling that there's a cancer stem cell, that when it's agitated by exposure to carcinogens or radiation or something, it goes nuts, and that we can't identify it from the other stem cells," he says. "How do you find this bad boy and pull him out&ltp>"And there's a nagging worry it's the same cell. We only know these cells by what they've done, and by the time they've become cancer, it's too late."&ltbr style="clear: both;"/> &lta style='font-size: 10px; color: maroon;' href='http://www.pheedo.com/hostedMorselClick.phphfmm=v2:5a347fada44af946320e281c6c671362:wfcoms1+BnkHE0IVBAvaNELyQEUsUL9MXF+nVXikafRLcqo4moram0RcyTu8Rqn0b744+KNISh6D5ldfh3g7dUArgadGDQ+EifVlzheivFk='>&ltimg border='0' title='Add to Facebook' alt='Add to Facebook' src='http://www.pheedo.com/images/mm/facebook.gif'/> &lta style='font-size: 10px; color: maroon;' href='http://www.pheedo.com/hostedMorselClick.phphfmm=v2:fd53ffc5efc7b0cdf22165548d0b736f:HjOPe7lzg2yB9Wbjqs0hFuPV1ycxq2rstA4rRwfFaoYCapZtqY7ogz046eP3LoJgv4YTPEf5K6aogpuPQOvc8gpksTp+KXOow+3PNjoYmJY='>&ltimg border='0' title='Add to Reddit' alt='Add to Reddit' src='http://www.pheedo.com/images/mm/reddit.png'/> &lta style='font-size: 10px; color: maroon;' href='http://www.pheedo.com/hostedMorselClick.phphfmm=v2:78b66705860de3290d4b4737db1667e6:Yw3oZGPb3l4v1qvNo+grdxMWKUojyWBwiHUJH/U5j05itfZLftd55G/4iKTorS2DBrn2fNi0kjpe0D7ODHFYhAE3BTyz16yw5HXWinCRIAY='>&ltimg border='0' title='Add to digg' alt='Add to digg' src='http://www.pheedo.com/images/mm/digg.gif'/> &lta style='font-size: 10px; color: maroon;' href='http://www.pheedo.com/hostedMorselClick.phphfmm=v2:91cd237b901a4363b9f1a304c980677b:Me+tY/qRG2ww+Ut/y3jxwOZk9AnLhZ6YbnIhhAXTBjkkubsVexEgeEQhLZQz3S840enjGFl0OwZiEueOesPOxsIFdLrDAQJwQL0v+pV1fMU='>&ltimg border='0' title='Add to Google' alt='Add to Google' src='http://www.pheedo.com/images/mm/google.png'/>&ltbr style="clear: both;"/> &ltimg alt="" style="border: 0; height:1px; width:1px;" border="0" src="http://www.pheedo.com/img.phdoi=376a2e880851ebfcf5355aabaeb1f9ae" height="1" />&ltimg src="http://www.pheedo.com/feeds/tracker.phpi=376a2e880851ebfcf5355aabaeb1f9ae" style="display: none;" border="0" height="1" alt=""/>&ltp>&lta href="http://feeds.wired.com/~a/wired/indexa=7HlFvh">&ltimg src="http://feeds.wired.com/~a/wired/indexi=7HlFvh" border="0">&ltimg src="http://feeds.wired.com/~r/wired/index/~4/367779300" height="1" />
    2008-08-18 05:00:00
  • Seniors often don't tell docs about surgery fears

    NEW YORK Reuters Health - Older people considering major orthopedic surgery only bring up about half of their concerns when they meet with their surgeon to discuss the operation, a new study shows.&ltdiv class="feedflare">&lta href="http://feeds.reuters.com/~f/reuters/UKhealtha=Tots3K">&ltimg src="http://feeds.reuters.com/~f/reuters/UKhealthi=Tots3K" border="0"> &lta href="http://feeds.reuters.com/~f/reuters/UKhealtha=M7u9Bk">&ltimg src="http://feeds.reuters.com/~f/reuters/UKhealthi=M7u9Bk" border="0"> &lta href="http://feeds.reuters.com/~f/reuters/UKhealtha=u9TfAk">&ltimg src="http://feeds.reuters.com/~f/reuters/UKhealthi=u9TfAk" border="0">&ltimg src="http://feeds.reuters.com/~r/reuters/UKhealth/~4/363244027" height="1" />
    2008-08-12 17:49:34
COUNTRIES    US STATES    US CITIES    CLASSIFIEDS    EVENTS    YELLOW PAGES    MAJOR CITIES    CATEGORY SITES     AVOO SEARCH     WORLD NEWS    POLLS